Rifampicin: a new rifamycin. I. Bacteriological studies.
D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D001407:Bacillus / Q000187:drug effects; D001419:Bacteria / Q000187:drug effects*; D002002:Brucella / Q000187:drug effects; D002509:Cephaloridine / Q000627:therapeutic use; D003016:Clostridium perfringens / Q000187:drug effects; D004755:Enterobacteriaceae / Q000187:drug effects; D006193:Haemophilus influenzae / Q000187:drug effects; D051379:Mice; D008837:Micrococcus / Q000187:drug effects; D009161:Mycobacterium / Q000187:drug effects; D009343:Neisseria / Q000187:drug effects; D010325:Pasteurella / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use; D012505:Sarcina / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013752:Tetracycline / Q000627:therapeutic use
D000667:Ampicillin; D013752:Tetracycline; D002509:Cephaloridine; D012293:Rifampin